Evidence map›Paper›PMID 37829280›Full record

ArticleFrontiers in genetics2023

Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfalls.

Line Dahl Jeppesen, Lotte Hatt, Ripudaman Singh, Palle Schelde, Katarina Ravn, Christian Liebst Toft, Maria Bach Laursen, Jakob Hedegaard, Inga Baasch Christensen, Bolette Hestbek Nicolaisen and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Line Dahl JeppesenARCEDI Biotech, Vejle, Denmark.
Lotte HattARCEDI Biotech, Vejle, Denmark.
Ripudaman SinghARCEDI Biotech, Vejle, Denmark.
Palle ScheldeARCEDI Biotech, Vejle, Denmark.
Katarina RavnARCEDI Biotech, Vejle, Denmark.
Christian Liebst ToftDepartment of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.
Maria Bach LaursenARCEDI Biotech, Vejle, Denmark.
Jakob HedegaardARCEDI Biotech, Vejle, Denmark.
Inga Baasch ChristensenARCEDI Biotech, Vejle, Denmark.
Bolette Hestbek NicolaisenARCEDI Biotech, Vejle, Denmark.
Lotte AndreasenDepartment of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Lars Henning PedersenDepartment of Gynecology and Obstetrics, Aarhus University Hospital, Aarhus, Denmark.
Ida VogelCenter for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
Dorte Launholt LildballeCenter for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
Aarhus University Hospital · DKAarhus University · DKAalborg University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical interpretationextravillous trophoblastsfetal cellsmonogenic disordersnoninvasive prenatal testingrepeat expansion disorders

Identifiers

PMID37829280
PMCPMC10565008
OpenAlexW4387097284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.